<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Trendlines Group Ltd. — News on 6ix</title>
    <link>https://6ix.com/company/trendlines-group-ltd</link>
    <description>Latest news and press releases for Trendlines Group Ltd. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 10 Mar 2026 12:30:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/trendlines-group-ltd" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d66356beedb30cb6fde737.webp</url>
      <title>Trendlines Group Ltd.</title>
      <link>https://6ix.com/company/trendlines-group-ltd</link>
    </image>
    <item>
      <title>IBI Ag Announces Successful Development of AI-Driven De Novo Protein Design Platform for Bioinsecticides</title>
      <link>https://6ix.com/company/trendlines-group-ltd/news/ibi-ag-announces-successful-development-of-ai-driven-de-novo-protein-design-platform-for-bioinsecticides-4</link>
      <guid isPermaLink="true">https://6ix.com/company/trendlines-group-ltd/news/ibi-ag-announces-successful-development-of-ai-driven-de-novo-protein-design-platform-for-bioinsecticides-4</guid>
      <pubDate>Tue, 10 Mar 2026 12:30:00 GMT</pubDate>
      <description>IBI Ag Ltd. (&apos;IBI Ag&apos;), a leader in sustainable agricultural solutions, has today announced the successful completion of its proof of concept (POC) for the AI-driven platform for de novo design of novel bioinsecticide proteins. This groundbreaking advancement marks a significant step forward in the quest for innovative, environmentally friendly pest control solutions.</description>
    </item>
    <item>
      <title>IBI Ag Completes $10 Million Series A Round Led by Corteva</title>
      <link>https://6ix.com/company/trendlines-group-ltd/news/ibi-ag-completes-dollar10-million-series-a-round-led-by-corteva-1</link>
      <guid isPermaLink="true">https://6ix.com/company/trendlines-group-ltd/news/ibi-ag-completes-dollar10-million-series-a-round-led-by-corteva-1</guid>
      <pubDate>Tue, 11 Nov 2025 13:30:00 GMT</pubDate>
      <description>IBI Ag, a pioneering crop protection company developing a wide array of bio-insecticides with a lower ecological footprint, today announced the successful completion of its Series A funding round for a total of $10 million.</description>
    </item>
    <item>
      <title>Escala Secures $4.5M in Funding to Accelerate Global Expansion of Its FDA-Approved Medical Device</title>
      <link>https://6ix.com/company/trendlines-group-ltd/news/escala-secures-dollar45m-in-funding-to-accelerate-global-expansion-of-its-fda-approved-medical-device</link>
      <guid isPermaLink="true">https://6ix.com/company/trendlines-group-ltd/news/escala-secures-dollar45m-in-funding-to-accelerate-global-expansion-of-its-fda-approved-medical-device</guid>
      <pubDate>Mon, 30 Jun 2025 12:00:00 GMT</pubDate>
      <description>Escala Medical Ltd. (&quot;Escala&quot;), a medical technology company specializing in innovative repair solutions for women with Pelvic Organ Prolapse (POP), today announced the successful completion of a $4.5 million funding round. The investment included the EIC Fund, following a €2.5 million grant awarded to Escala in October 2023 through the prestigious EIC Accelerator program. The round also included participation from private investors in the United States and Israel.</description>
    </item>
    <item>
      <title>EcoPhage Appoints José Alfredo García to its Board Of Directors</title>
      <link>https://6ix.com/company/trendlines-group-ltd/news/ecophage-appoints-jose-alfredo-garcia-to-its-board-of-directors-1</link>
      <guid isPermaLink="true">https://6ix.com/company/trendlines-group-ltd/news/ecophage-appoints-jose-alfredo-garcia-to-its-board-of-directors-1</guid>
      <pubDate>Mon, 23 Jun 2025 13:34:00 GMT</pubDate>
      <description>EcoPhage, a leader in the development and commercialization of sustainable phage-based biopesticides for bacterial plant diseases, expecting its first U.S. EPA approval, is pleased to announce the appointment of Mr. José Alfredo García, to its Board of Directors. With extensive experience in building and scaling global agribusiness platforms, García joins at a pivotal time as the company prepares for commercial rollout in key markets</description>
    </item>
  </channel>
</rss>